SCHEMBL29475643

SCHEMBL29475643

O=C(O)CCOCCON1C(=O)c2ccccc2C1=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.75
ALDH1A1 P00352 4/20 0.65
CYP1A2 P05177 2/20 0.53
CYP2C9 P11712 1/20 0.53
KDM4E B2RXH2 2/20 0.48
TP53 P04637 1/20 0.48
GLA P06280 1/20 0.48
POLB P06746 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
HPGD P15428 1/20 0.48
ALOX12 P18054 1/20 0.48
NFKB1 P19838 1/20 0.48
APEX1 P27695 1/20 0.48
MAPK1 P28482 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CA12 O43570 1/20 0.45
CA9 Q16790 1/20 0.45
RECQL P46063 1/20 0.44
PPARD Q03181 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14237856 1.00 GAA (0.75) GAAALDH1A1CYP1A2CYP2C9KDM4E
SCHEMBL14237920 1.00 GAA (0.75) GAAALDH1A1CYP1A2CYP2C9KDM4E
SCHEMBL12028883 0.87 GAA (1.00) GAAALDH1A1CYP1A2CYP2C9KDM4E
SCHEMBL3077457 0.87 GAA (1.00) GAAALDH1A1CYP1A2CYP2C9KDM4E
SCHEMBL12029057 0.87 GAA (1.00) GAAALDH1A1CYP1A2CYP2C9KDM4E
SCHEMBL18262805 0.84 GAA (0.59) GAAALDH1A1CYP1A2CYP2C9KDM4E
SCHEMBL26353713 0.84 GAA (0.69) GAAALDH1A1CYP1A2CYP2C9POLB
SCHEMBL2385576 0.82 GAA (0.83) GAAALDH1A1CYP1A2CYP2C9POLB
SCHEMBL12144000 0.82 GAA (0.83) GAAALDH1A1CYP1A2CYP2C9POLB
SCHEMBL3251022 0.82 GAA (0.83) GAAALDH1A1CYP1A2CYP2C9POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119455003-A Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2025-02-18 CN disclosed
CN-119455004-A Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2025-02-18 CN disclosed
CN-113660957-B Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2024-12-13 CN disclosed
CN-116457023-A antibody-TLR agonist conjugates, methods and uses thereof AMBRX公司 2023-07-18 CN disclosed
EP-4199968-A1 ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF Ambrx, Inc. (US) 2023-06-28 EP disclosed
WO-2022040596-A1 ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF AMBRX, INC. (US) 2022-02-24 WO disclosed